Amy Crouse, LPN in Concordia, KS - Licensed Practical Nurse

Amy Crouse, LPN is a Licensed Practical Nurse based in Concordia, Kansas. Amy Crouse is licensed to practice in Kansas (license number 32134) and her current practice location is 210 W 21st St, Concordia, Kansas. She can be reached at her office (for appointments etc.) via phone at (785) 243-8900.

NPI number for Amy Crouse is 1891244729 and her current mailing address is Po Box 747, Manhattan, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1891244729.

Contact Information

	Amy Crouse, LPN
	210 W 21st St, Concordia, KS 66901-5200
	(785) 243-8900
	(785) 243-8933

Provider's Profile

Full Name	Amy Crouse
Gender	Female
Speciality	Licensed Practical Nurse
Location	210 W 21st St, Concordia, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1891244729
Provider Enumeration Date: 10/04/2016
Last Update Date: 10/04/2016

Medical Identifiers

Medical identifiers for Amy Crouse such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1891244729	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	32134 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amy Crouse is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Amy Crouse, LPN Po Box 747, Manhattan, KS 66505-0747 Ph: (785) 587-4300	Amy Crouse, LPN 210 W 21st St, Concordia, KS 66901-5200 Ph: (785) 243-8900

News Archive

Researchers demonstrate the safety of potential vaccine against mesothelioma

Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient's own dendritic cells (DC) with antigen from the patient's tumor, was able to induce a T-cell response against mesothelioma tumors.

Bellus Health reports net loss of $5.8M for second-quarter vs. net income of $14.27M for previous year

BELLUS Health Inc. reported today its financial results for the second quarter ended June 30, 2010. The Company also announced new initiatives to reduce its annual expenditures ("burn rate") by focusing its efforts on existing products and on supporting current and future strategic partnerships. All currency figures reported in this press release, including comparative figures, are in Canadian dollars, unless otherwise specified.

Ohr Pharmaceutical partners with CSHL to develop trodusquemine and related analogs

Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) today announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogs.

Text messaging intervention may help smokers abstain from smoking relative to controls

A new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine found that smokers who received a text messaging intervention were more likely to abstain from smoking relative to controls. The paper is published in the Journal of Medical Internet Research mHealth and uHealth.

Study: Children with type 1 diabetes five times more likely to be admitted to hospital

Children living with type 1 diabetes are nearly five times more likely to be admitted to hospital than non-diabetic children, a new study (attached) has found.

Amy Crouse, LPN - Licensed Practical Nurse in Concordia, KS